Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0536-1431

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 0536-1431). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fexofenadine-fig1 (Fexofenadine Fig1)

Packaging label for Rugby Allergy & Congestion tablets containing Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets, USP. The label shows a strength of 60 mg/120 mg and contains 20 extended-release tablets. The label also indicates non-drowsy antihistamine and nasal decongestant, with indoor/outdoor relief for nasal and sinus congestion and allergy symptoms. The labeler is Rugby Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.